Moderna
MRNA
#1337
Rank
ยฃ12.24 B
Marketcap
ยฃ31.33
Share price
1.35%
Change (1 day)
14.41%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: ยฃ12.24 Billion

As of February 2026 Moderna has a market cap of ยฃ12.24 Billion. This makes Moderna the world's 1337th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ12.24 B35.23%
2025ยฃ9.05 B-26.44%
2024ยฃ12.30 B-58.65%
2023ยฃ29.76 B-47.82%
2022ยฃ57.03 B-25.23%
2021ยฃ76.28 B151.54%
2020ยฃ30.32 B504.16%
2019ยฃ5.01 B26.92%
2018ยฃ3.95 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Moderna was reported to be:

ยฃ12.23 Billion
by Nasdaq info icon info icon
ยฃ12.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ413.80 B 3,280.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ214.92 B 1,655.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ216.50 B 1,668.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
ยฃ0.41 B-96.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.18 B-82.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.61 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ34.06 B 178.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ6.98 B-42.98%๐Ÿ‡บ๐Ÿ‡ธ USA